1. Atassi,M.Z., Ruan,K.H., Jinnai,K., Oshima,M. and Ashizawa,T. (1992) Proc. Natl Acad. Sci. USA, 89, 5852–5856.
2. Brumeanu,T.D., Zaghouani,H., Elahi,E., Daian,C. and Bona,C.A. (1995) J. Immunol., 154, 3088–3095.
3. Cibotti,R., Kanellopoulos,J.M., Cabaniols,J.P., Halle,P.O., Kosmatopoulos,K., Sercarz,E. and Kourilsky,P. (1992) Proc. Natl Acad. Sci. USA, 89, 416–420.
4. Francis,G.E., Delgado,C. and Fisher,D. (1992) In Ahern,T.J. and Manning,M.C. (eds), PEG-modified Proteins: Stability of Protein Pharmaceuticals, In Vivo Pathways of Degradation and Strategies for Protein Stabilization. Plenum Press, New York, pp. 235–263.
5. Goodnow,C.C., Crosbie,J., Jorgensen,H., Brink,R.A. and Basten,A. (1989) Nature, 342, 385–391.